Episode Details

Please support this podcast by checking out our sponsors:
- Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad
- SurveyMonkey, Using AI to surface insights faster and reduce manual analysis time - https://get.surveymonkey.com/tad
- Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily


Support The Automated Daily directly:
Buy me a coffee: https://buymeacoffee.com/theautomateddaily

Today's topics:

Synthetic cells complete lab cycle - University of Minnesota researchers unveiled “SpudCells,” liposome-based synthetic cells that can grow, copy DNA, and divide in a dish—an eye-catching step in bottom-up artificial life research.

CAR-T strategy for glioblastoma - A Nature study points to GPNMB-targeting CAR-T cells that may hit both glioblastoma tumor cells and tumor-supporting macrophages, aiming for more durable brain cancer control.

GLP-1 drugs and PAD outcomes - An observational TriNetX analysis links GLP-1 receptor agonists like semaglutide with lower death, hospitalization, and amputation risks in people with type 2 diabetes plus peripheral artery disease (PAD), pending randomized trials.

Gene therapy sickle cell milestone - Louisiana doctors report a 23-year-old man is functionally cured of sickle cell disease after FDA-approved gene therapy, highlighting expanding real-world access to gene-altering treatments.

Supreme Court upholds birthright citizenship - In Trump v. Barbara, the U.S. Supreme Court struck down a 2025 executive order limiting birthright citizenship, reaffirming the 14th Amendment’s long-standing interpretation.

UN warns AI governance window closing - A UN scientific panel warns global AI rules are falling behind fast, citing risks from deepfakes, cybercrime, disinformation, and unequal access to computing power ahead of the Geneva AI Governance dialogue.

Malaria vaccine targets for T-cells - Researchers identified conserved malaria parasite peptides presented to CD8+ T cells across stages and species, offering a data-driven shortlist for broader T-cell–based malaria vaccines.

NASA funds new lunar landers - NASA awarded nearly $600 million to Astrobotic, Firefly, and Intuitive Machines for four lunar cargo lander deliveries by 2028, gathering comparable hazard and environment data across Moon sites.

Episode Transcript

Synthetic cells complete lab cycle
Let’s start in the lab—where the line between chemistry and biology just got a little blurrier. Researchers at the University of Minnesota report they’ve created what they call “SpudCells”: tiny spheres made from simple components that can take in resources, expand, replicate their lab-made DNA, and then divide. The headline is that they’re aiming for a full synthetic cell cycle assembled from the bottom up, rather than tweaking an existing organism. The team also saw a basic form of “survival advantage,” where some genetic variants outcompeted others. Important caveats: this is a preprint, not yet peer-reviewed, and these systems still depend heavily on carefully provided ingredients. They also tend to break down after a few generations. Still, it’s a striking step toward programmable, purpose-built biology—while raising new questions about oversight and where this research leads.